PemB, a type III secretion effector in Pseudomonas aeruginosa, affects Caenorhabditis elegans life span

Shira Zelikman1,2, Reut Dudkevich1, Hadar Korenfeld-Tzemach1,2

  • 1The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Max and Anna Webb, 5290002, Ramat Gan, Israel.

Heliyon
|April 29, 2024
PubMed

Insights

Pseudomonas aeruginosa

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pathogen Research

Background:

  • Pseudomonas aeruginosa is a major opportunistic pathogen responsible for numerous infections.
  • The Type III secretion system (T3SS) is a key virulence factor in P. aeruginosa, delivering effector proteins into host cells.
  • Only a limited number of T3SS effectors have been identified, highlighting the need for further discovery.

Purpose of the Study:

  • To validate the virulence of a newly identified T3SS effector, PemB, from P. aeruginosa.
  • To investigate the molecular mechanisms underlying PemB-mediated virulence.
  • To identify host factors that interact with PemB and contribute to pathogenesis.

Main Methods:

  • Utilized a Caenorhabditis elegans infection model to assess PemB virulence.
  • Employed a high-throughput yeast-based screen to identify PemB-interacting proteins.
  • Investigated the role of identified interacting proteins in PemB-induced toxicity.

Main Results:

  • PemB was confirmed as a virulent effector, causing intestinal barrier damage and host death in C. elegans.
  • Identified EFT1, a protein interacting with PemB, with an ortholog (eef-2) in C. elegans.
  • Demonstrated that silencing eef-2 in C. elegans abrogated PemB's toxic effects, indicating eef-2 is essential for PemB virulence.

Conclusions:

  • PemB is a novel virulent T3SS effector of Pseudomonas aeruginosa.
  • The interaction between PemB and the host factor eef-2 is critical for P. aeruginosa pathogenesis.
  • This study provides new insights into P. aeruginosa virulence mechanisms and potential therapeutic targets.